ECONOMIC BURDEN ASSOCIATED WITH IMMUNERELATED ADVERSE EVENTS INDUCED BY IMMUNE CHECKPOINT INHIBITORS AMONG OLDER ADULTS WITH NON-SMALL CELL LUNG CANCER

被引：0
|
作者：
Rong, Y. [1 ]
Ramachandran, S. [2 ]
Bhattacharya, K. [3 ]
Yang, Y. [4 ]
Chang, Y. [5 ]
Earl, S. [4 ]
Bentley, J. [3 ]
机构：
[1] Univ Mississippi, Sch Pharm, Amherst, MA USA
[2] Sch Pharm, Oxford, MS USA
[3] Sch Pharm, University, MS USA
[4] Univ Mississippi, Sch Pharm, University, MS USA
[5] Univ Mississippi, Sch Appl Sci, University, MS USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE37
引用
收藏
页码：S66 / S66
页数：1
相关论文
共 50 条
  • [1] Incidence and risk factors of immune-related adverse events induced by immune checkpoint inhibitors among older adults with non-small cell lung cancer
    Rong, Yiran
    Bentley, John P.
    Bhattacharya, Kaustuv
    Yang, Yi
    Chang, Yunhee
    Earl, Sally
    Ramachandran, Sujith
    [J]. CANCER MEDICINE, 2024, 13 (01):
  • [2] Checkpoint Inhibitors for Non-Small Cell Lung Cancer Among Older Adults
    Rawad Elias
    Joshua Morales
    Carolyn Presley
    [J]. Current Oncology Reports, 2017, 19
  • [3] Checkpoint Inhibitors for Non-Small Cell Lung Cancer Among Older Adults
    Elias, Rawad
    Morales, Joshua
    Presley, Carolyn
    [J]. CURRENT ONCOLOGY REPORTS, 2017, 19 (09)
  • [4] Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non-Small Cell Lung Cancer
    Shankar, Bairavi
    Zhang, Jiajia
    Naqash, Abdul Rafeh
    Forde, Patrick M.
    Feliciano, Josephine L.
    Marrone, Kristen A.
    Ettinger, David S.
    Hann, Christine L.
    Brahmer, Julie R.
    Ricciuti, Biagio
    Owen, Dwight
    Toi, Yukihiro
    Walker, Paul
    Otterson, Gregory A.
    Patel, Sandip H.
    Sugawara, Shunichi
    Naidoo, Jarushka
    [J]. JAMA ONCOLOGY, 2020, 6 (12) : 1952 - 1956
  • [5] Pneumonitis associated with immune checkpoint inhibitors among patients with non-small cell lung cancer
    Shannon, Vickie R.
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2020, 26 (04) : 326 - 340
  • [6] Neurological Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Current Perspectives and New Development
    Cheng, Ke
    Wang, Yuqing
    Zhou, Yuwen
    Xia, Ruolan
    Tang, Liansha
    Liu, Jiyan
    [J]. CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2021, 15
  • [7] Immune checkpoint inhibitors in non-small cell lung cancer
    Eberhardt, Wilfried Ernst Erich
    [J]. ONKOLOGE, 2017, 23 (10): : 838 - 844
  • [8] Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Herzberg, Benjamin
    Campo, Meghan J.
    Gainor, Justin F.
    [J]. ONCOLOGIST, 2017, 22 (01): : 81 - 88
  • [9] Immune Checkpoint Inhibitors in Real-World Treatment of Older Adults with Non-Small Cell Lung Cancer
    Muchnik, Eugene
    Loh, Kah Poh
    Strawderman, Myla
    Magnuson, Allison
    Mohile, Supriya G.
    Estrah, Vered
    Maggiore, Ronald J.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2019, 67 (05) : 905 - 912
  • [10] Fatal Adverse Events Associated With Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Yu, Xiaolin
    Zhang, Xiaomei
    Yao, Ting
    Zhang, Ye
    Zhang, Yanxia
    [J]. FRONTIERS IN MEDICINE, 2021, 8
12345